Australia’s Therapeutic Goods Administration (TGA) has issued a safety warning regarding the discontinuation of Prolia ...
Biosimilar denosumab offers significant cost savings and improved access to treatment, alleviating financial burdens in ...
Israel’s Teva Pharmaceutical Industries has announced that the European Commission (EC) has granted marketing authorizations ...
MONTREAL, Nov. 25, 2025 (GLOBE NEWSWIRE) -- bonap, Alexis Nihon’s new food court, is now open! The community can gather in the redesigned space to enjoy tasty moments in a ...
You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply.
Following the positive opinions of the Committee for Medicinal Products for Human Use (CHMP), the European Commission has granted marketing authorizations for Teva's biosimilars PONLIMSI and DEGEVMA e ...
Following the positive opinions of the Committee for Medicinal Products for Human Use (CHMP), the European Commission has ...
TipRanks on MSN
Dr. Reddy’s Gains EU Approval for Denosumab Biosimilar
Dr Reddy’s Laboratories ( ($RDY) ) has provided an update. Dr. Reddy’s Laboratories announced on November 24, 2025, that it has received European ...
Indian insurance brokers should be licenced for perpetuity instead of three years, said a top official of the Insurance Brokers Association of India (IBAI).
Sensex down 314 points, Nifty50 under 25,900; Adani Enterprises, TMPV, Trent shares among top losers
Adani Enterprises emerged as the top loser in today’s trade, dropping by nearly 3%, followed by Tata Motors Passenger Vehicles and Trent, which came down by 1.49% and 1.39% respectively.
Dr. Reddy's Laboratories secured European Commission approval for AVT03, a biosimilar to Prolia and Xgeva, for osteoporosis ...
TipRanks on MSN
Alvotech’s AVT03 Biosimilar Gains European Approval
The latest update is out from Alvotech ( (ALVO) ).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results